Michael Sofman, MD
Dermatology · Hollywood, FLNPI 1508834458
Payments from drug & device makers
Across 144 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$667
- AbbVie$387
- Amgen$355
- Sanofi$326
- Novartis$264
- Pfizer$209
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,301100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 29 | $667 |
| AbbVie | 20 | $387 |
| Amgen | 13 | $355 |
| Sanofi | 11 | $326 |
| Novartis | 11 | $264 |
| Pfizer | 10 | $209 |
| Regeneron Healthcare Solutions, Inc. | 7 | $182 |
| Mallinckrodt Hospital Products Inc. | 7 | $162 |
| E.r. Squibb & Sons, L.L.C. | 7 | $130 |
| UCB, Inc. | 4 | $108 |
| Sun Pharmaceutical Industries Inc. | 2 | $56 |
| Elekta, Inc. | 1 | $49 |
| Bristol Myers Squibb | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
| Genentech USA, Inc. | 2 | $41 |
| Biofrontera Inc. | 2 | $37 |
| Verrica Pharmaceuticals Inc. | 1 | $33 |
| Galderma Laboratories, L.p. | 2 | $32 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Incyte Corporation | 1 | $28 |
| Strata Skin Sciences, Inc. | 2 | $28 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $25 |
| LEO Pharma Inc. | 1 | $19 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
| Almirall LLC | 1 | $15 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $9 |
How this compares
$3,309 in reported general payments places this provider in the 50th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Ir-DrDoxycycline Monohydrate | 13 | $8,683 |
| Mometasone Furoate | 168 | $3,192 |
| Betamethasone Dipropionate | 82 | $3,159 |
| Ketoconazole | 196 | $2,748 |
| Metronidazole | 37 | $2,188 |
| Ciclopirox | 44 | $1,911 |
| Fluocinonide-EFluocinonide/Emollient Base | 28 | $1,758 |
| Fluocinonide | 27 | $1,756 |
| Imiquimod | 46 | $1,684 |
| Tacrolimus | 11 | $1,389 |
| Triamcinolone Acetonide | 122 | $1,052 |
| Clobetasol Propionate | 18 | $1,031 |
| Clindamycin Phosphate | 31 | $681 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $630 |
| ValacyclovirValacyclovir Hcl | 33 | $616 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Hollywood
- Eduardo WeissHollywood$5.5M
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
- Hector Wiltz JrMiami$6.4M
- Javier Alonso-LlamazaresCoral Gables$5.6M
- Francisco KerdelMiami$5.1M
- Jason SluzevichJacksonville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.